NorPept
Ver Todos los Péptidos
fatLoss

Semamax

Semaglutide

Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.

Datos Moleculares

99.3%

Pureza

4113.58 g/mol

Peso Molecular

SEM-2026-0267

Número de Lote

HPLC + Mass Spectrometry

Método de Prueba

Pureza Verificada

Probado en Laboratorio

Secuencia de Aminoácidos

Modified GLP-1(7-37) analog with C-18 fatty acid chain

Estudios de Investigación

Insulin secretion and blood glucose regulation
Appetite and food intake reduction
Weight management in obese and overweight patients
Cardiometabolic marker improvement
Cardiovascular risk reduction in diabetics

Verificación de Laboratorio

Escanear para verificar

Número de Lote: SEM-2026-0267

Pureza: 99.3%

Perfil de Efectos

Recovery
1
Energy
2
Anti-Aging
2
Muscle
1
Fat Loss
5
Skin
1
Sleep
1
Cognitive
1
Valoración de Expertos
4.5

Beneficios Clave

Enhances insulin secretion and lowers blood glucose
Significantly reduces appetite and food intake
Proven weight loss effects in obese and overweight patients
Improves cardiometabolic markers (HbA1c, LDL, blood pressure)
Reduces risk of major cardiovascular events in diabetics
Once-weekly dosing with sustained effect

Combina Bien Con

Estos péptidos se combinan frecuentemente con Semamax para obtener mejores resultados.

¿Listo para explorar? Semamax?

Haz nuestro test guiado para encontrar péptidos que se ajusten a tus objetivos de investigación, o navega por nuestro catálogo completo.